XML 114 R70.htm IDEA: XBRL DOCUMENT v3.21.1
Principal activities and organization (Details 2)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Dec. 08, 2020
CNY (¥)
shares
Jun. 18, 2020
CNY (¥)
May 31, 2014
shares
Dec. 31, 2020
CNY (¥)
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
CNY (¥)
shares
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2018
CNY (¥)
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 08, 2020
$ / shares
Jun. 18, 2020
$ / shares
shares
Dec. 31, 2017
CNY (¥)
VIEs and VIEs' subsidiaries                        
Total assets       ¥ 422,287,794,000   ¥ 259,723,704,000     $ 64,718,436      
Total liabilities       200,668,678,000   159,099,473,000     $ 30,753,818      
Total net revenues       745,801,886,000 $ 114,299,140 576,888,484,000   ¥ 462,019,759,000        
Net income/(loss)       49,337,246,000 7,561,264 11,890,092,000   (2,800,550,000)        
Net cash provided by/(used in) operating activities       42,544,317,000 6,520,202 24,781,220,000   20,881,422,000        
Net cash used in investing activities       (57,810,588,000) (8,859,860) (25,349,357,000)   (26,078,992,000)        
Net cash provided by financing activities       71,071,595,000 10,892,198 2,572,467,000   11,219,928,000        
Net increase/(decrease) in cash, cash equivalents, and restricted cash       50,722,944,000 7,773,632 2,410,221,000   7,703,521,000        
Cash, cash equivalents, and restricted cash at beginning of the year       39,912,279,000 6,116,824 37,502,058,000   29,798,537,000        
Cash, cash equivalents, and restricted cash at end of year, including cash and cash equivalents classified within assets held for sale       90,635,223,000 $ 13,890,456 39,912,279,000 $ 6,116,824 37,502,058,000        
Common stock value per share | $ / shares                 $ 0.00002      
Total shareholders' equity(deficit) of the Group's VIEs and VIEs' subsidiaries       ¥ 204,485,908,000   ¥ 84,659,847,000   ¥ 60,866,860,000 $ 31,338,839     ¥ 52,388,703,000
Common Stock [Member]                        
VIEs and VIEs' subsidiaries                        
Stock issued during the period shares | shares       155,850,684 155,850,684 8,127,302 8,127,302 27,106,948        
Total shareholders' equity(deficit) of the Group's VIEs and VIEs' subsidiaries       ¥ 404,000   ¥ 381,000   ¥ 380,000       ¥ 377,000
Hong Kong Stock Exchange                        
VIEs and VIEs' subsidiaries                        
Proceeds from issuance of offering   ¥ 31,300,000,000                    
Class A ordinary shares                        
VIEs and VIEs' subsidiaries                        
Ordinary shares, shares issued | shares       2,685,542,982   2,520,271,138     2,685,542,982   152,912,100  
Class A ordinary shares | HKD                        
VIEs and VIEs' subsidiaries                        
Common stock value per share | $ / shares                     $ 226  
Class A ordinary shares | IPO [Member]                        
VIEs and VIEs' subsidiaries                        
Stock issued during the period shares | shares     166,120,400                  
JD Health International Inc | IPO [Member] | Common Stock [Member]                        
VIEs and VIEs' subsidiaries                        
Stock issued during the period shares | shares 439,185,000                      
Sale of stock issue price per share | $ / shares                   $ 70.58    
Sale of stock net consideration received on the transaction ¥ 25,700,000,000                      
VIEs and their subsidiaries                        
VIEs and VIEs' subsidiaries                        
Total assets       ¥ 65,593,705,000   ¥ 38,749,631,000            
Total liabilities       59,297,604,000   43,734,593,000            
Total net revenues       86,054,223,000   59,306,001,000   37,561,128,000        
Net income/(loss)       (422,044,000)   (2,268,090,000)   (2,646,122,000)        
Net cash provided by/(used in) operating activities       9,911,601,000   953,673,000   (1,144,849,000)        
Net cash used in investing activities       (11,052,862,000)   (6,450,150,000)   (7,596,181,000)        
Net cash provided by financing activities       2,659,287,000   5,542,926,000   8,902,074,000        
Net increase/(decrease) in cash, cash equivalents, and restricted cash       1,518,026,000   46,449,000   161,044,000        
Cash, cash equivalents, and restricted cash at beginning of the year       926,653,000   880,204,000   719,160,000        
Cash, cash equivalents, and restricted cash at end of year, including cash and cash equivalents classified within assets held for sale       2,444,679,000   926,653,000   880,204,000        
Registered capitals and PRC statutory reserves of the Group's consolidated VIEs       3,140,310,000                
Total shareholders' equity(deficit) of the Group's VIEs and VIEs' subsidiaries       5,570,027,000   (4,984,962,000)            
VIEs and their subsidiaries | JD Variable Interest Entity with the intra-company balances and transactions within the Group eliminated [Member]                        
VIEs and VIEs' subsidiaries                        
Total assets       65,593,705,000   38,749,631,000            
Total liabilities       32,266,366,000   21,328,216,000            
Total net revenues       ¥ 36,976,185,000   ¥ 26,845,232,000   ¥ 17,779,765,000